您当前的位置:
首页 >
文章列表页 >
Construction of RNAi recombinant targeting focal adhesion kinase and its effect on resisting multicellular spheroids formation in human colon HT29 cells
更新时间:2025-01-15
    • Construction of RNAi recombinant targeting focal adhesion kinase and its effect on resisting multicellular spheroids formation in human colon HT29 cells

    • Journal of Army Medical University   Vol. 31, Issue 17, Pages: 1633-1636(2009)
    • 作者机构:

      1. 第三军医大学西南医院肿瘤科

      2. 重庆邮电大学生物信息学院

    • CLC: R735.35;R394-33;R730.23
    • Published:2009,

      Published Online:15 September 2009,

    移动端阅览

  • CHEN YU-YING, XIANG LIU-XIN, YANG LI, et al. Construction of RNAi recombinant targeting focal adhesion kinase and its effect on resisting multicellular spheroids formation in human colon HT29 cells. [J]. Journal of army medical university, 2009, 31(17): 1633-1636. DOI:

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Construction and identification of CA916798 eukaryotic expression vector for RNA interference
Reversing multi-cellular resistance of colon carcinoma cells by suppressing focal adhesion kinase through FAK/Akt/NF-κB signaling pathway
Effect of targeted Sox2 silencing on expression of β-catenin and TIF1γ in human breast cancer MDA-MB-231 cells

Related Author

WANG Hai-jing
YANG He-ping
ZHOU Xiang-dong
Chen Yuying
Xiang Liuxin
Pan Feng
Jiang Jinyan
Yang Li

Related Institution

Department of Respiratory Diseases,Southwest Hospital,Third Military Medical University
Key Laboratory of Molecular Biology, College of Bio-information, Chongqing University of Posts and Telecommunications
Department of Otorhinolaryngology, the First Affiliated Hospital of Chongqing Medical University
Department of Oral and Maxillofacial Surgery, School of Stomatology, Department of Pathology, College of Basic Medicine, North China University of Science and Technology
Department of Pathology, Research Center for Molecular Medicine and Cancer, Chongqing Medical University
0